Status:
WITHDRAWN
MS and NMOSD in African-Americans
Lead Sponsor:
Jagannadha R Avasarala
Conditions:
Multiple Sclerosis
Neuromyelitis Optica
Eligibility:
All Genders
18-80 years
Brief Summary
This is a prospective study that aims to collect and review neuromyelitis optica spectrum disorder (NMOSD) data from African American patients with a known diagnosis of multiple sclerosis (MS). It is ...
Detailed Description
African-Americans with MS are high risk for ambulatory difficulty given aggressive disease phenotype. Disease responsiveness to FDA-approved drugs is also marginal at best. A positive correlation bet...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- between the ages of 18 and 80
- are African-American
- have a diagnosis of MS and later diagnosis of NMOSD
- have been seen at the University of Kentucky's Kentucky Neuroscience Institute
Exclusion
Key Trial Info
Start Date :
July 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04131673
Start Date
July 5 2019
End Date
December 31 2023
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40536